UMIN ID: UMIN000001364
Registered date:09/09/2008
Phase II trial of TS-1 and cisplatin in patients with Carcinoma of Unknown Primary Sites (KMOG 0607)
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Carcinoma of Unknown Primary Sites |
| Date of first enrollment | 2006/07/14 |
| Target sample size | 38 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Treatment: TS-1+CDDP |
Outcome(s)
| Primary Outcome | Response Rate |
|---|---|
| Secondary Outcome | Safety, Overall survival, Progression free survival |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | (1)Massive pleural effusion or massive ascites (2)Symptomatic brain metastases |
Related Information
| Primary Sponsor | Kyushu Medical Oncology Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Kyushu Medical Oncology Group |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Hitoshi Kusaba |
| Address | 3-1-1 Maidashi, Higashi-ku, Fukuoka812-8582, Japan Japan |
| Telephone | 092-642-5232 |
| hkusaba@intmed1.med.kyushu-u.ac.jp | |
| Affiliation | Kyushu University Hospital Division of Hematology and Oncology |
| scientific contact | |
| Name | Eishi Baba |
| Address | 3-1-1 Maidashi, Higashi-ku, Fukuoka812-8582, Japan Japan |
| Telephone | 092-642-5232 |
| e-baba@intmed1.med.kyushu-u.ac.jp | |
| Affiliation | Kyushu University Hospital Division of Hematology and Oncology |